NeutriSci International Inc.
NRXCF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 465.9% | 8.5% | -22.8% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -9.5% | -25.4% | -7.9% | 3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $2 | $1 |
| SG&A Expenses | $1 | $1 | $2 | $2 |
| Sales & Mktg Exp. | -$0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $2 | $2 |
| Operating Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | -150.8% | -1,857.6% | -2,607.2% | -1,710.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$1 | -$2 | -$2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | -168.4% | -1,943.5% | -2,618.3% | -1,670.7% |
| EPS | -0.005 | -0.01 | -0.014 | -0.014 |
| % Growth | 53.5% | 27.2% | 2.2% | – |
| EPS Diluted | -0.005 | -0.01 | -0.014 | -0.014 |
| Weighted Avg Shares Out | 166 | 159 | 143 | 116 |
| Weighted Avg Shares Out Dil | 166 | 159 | 143 | 116 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$2 | -$2 |
| % Margin | -160.2% | -1,886.5% | -2,579.9% | -1,664.3% |